✦ LIBER ✦

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

✍ Scribed by Deepa Wadhwa; Nazanin Fallah-Rad; Debjani Grenier; Marianne Krahn; Tielan Fang; Roien Ahmadie; Jonathan R. Walker; Danica Lister; Rakesh C. Arora; Ivan Barac; Andrew Morris; Davinder S. Jassal

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 198 KB
Volume: 117
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-008-0260-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline diastolic dysfunction as a pred

Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer

✍ Alexandre Cochet; Gaetan Quilichini; Inna Dygai-Cochet; Claude Touzery; Michel T 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 305 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

Implementation of trastuzumab in conjunc

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands

✍ L. de Munck; M. Schaapveld; S. Siesling; J. Wesseling; A. C. Voogd; V. C. G. Tja 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 192 KB

Cardiotoxicity and incidence of brain me

Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials

✍ Emilio Bria; Federica Cuppone; Monica Fornier; Cecilia Nisticò; Paolo Carlini; M 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 289 KB

A retrospective study of earliest indica

A retrospective study of earliest indicators of recurrence in patients on eastern cooperative oncology group adjuvant chemotherapy trials for breast cancer. A preliminary report

✍ Kishan J. Pandya; Eleanor T. McFadden; Leslie A. Kalish; Douglass C. Tormey; Sam 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 3 views

A retrospective review of the Eastern Cooperative Oncology Group adjuvant chemotherapy studies EST 5177 and EST 6177 was performed in order to ascertain the first indicator of relapse in women with breast cancer and pathologically positive axillary lymph nodes. Of 856 evaluable patients, 208 have re

Nonpharmacologic factors in the developm

Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer

✍ Paul B. Jacobsen; Maria Die-Trill; Jimmie C. Holland; Michael A. Andrykowski; Wi 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB